HbA1c Testing Market by Products (Instruments and Consumables), Technology (Ion-Exchange HPLC, Boronate Affinity Chromatography, Turbidimetric Inhibition Immunoassay, and Direct Enzymatic Assay), End Users (Hospitals & Clinics, Diagnostic Laboratories, and Home Care) – Global Outlook & Forecast 2021-2031
According to the deep-dive market assessment study conducted by Growth+ Reports, the global HbA1c testing market was pegged at ~US$ 1.3 billion in 2020. The market is expected to witness a CAGR of ~8.5% from 2021 to 2031.
Factors contributing to the growth of the global HbA1c testing market include technological advancements in analyzers and new product launches. Moreover, the rising geriatric population, increasing incidence of diabetes, and rising awareness about diabetes, its self-management, and associated health risks are some of the other factors playing a pivotal role in driving the HbA1c testing market growth. However, certain factors such as genetic variants and modified derivatives of hemoglobin that can affect the accuracy of HbA1c are likely to hinder the adoption of the HbA1c test to a certain extent.
Diabetes is one of the major health challenges of the 21st century, as the number of adults living with diabetes has tripled over the past 20 years. The growing prevalence of diabetes is one of the major factors playing a key role in the growth of the HbA1c testing market. According to Diabetes Research Institute Foundation, 34.2 million people, or 10.5% of the U.S. population, have diabetes. In 2018, an estimated 1.5 million new cases of diabetes were diagnosed among U.S. adults aged 18 years or older. HbA1c measures the glycosylation of hemoglobin and provides a measure of the average blood glucose over the approximately 60-day half-life of red blood cells. It’s one of the commonly used tests to diagnose prediabetes and diabetes. Therefore, the rising prevalence of diabetes is expected to fuel the growth of the HbA1c testing market.
Government organizations, standardization committees, and companies developing HbA1c tests have worked tremendously on improving HbA1c testing in the past few years. Companies are developing new and advanced products in the market to satisfy the unmet needs of the population. For instance, in May 2022, OmegaQuant (Sioux Falls, SD) announced the launch of an HbA1c Test, with an at-home sample collection kit. The test allows people to measure the amount of blood sugar (glucose) in the blood. When glucose builds up in the blood, it binds to a protein called hemoglobin. Moreover, in 2018, Abbott launched Afinion 2 analyzer in the U.S., a multi-assay test system that helps people get the HbA1c test results within 3 minutes. Such new product launches are boosting the growth of the HbA1c testing market.
Companies in the market are adopting growth strategies such as entering partnerships, collaborations, or signing agreements. Through such strategies, they can market their products in other regions. For instance, in May 2020, EKF Diagnostics signed a 3-year distribution agreement with Tosoh Europe N.V. for a Quo-Test HbA1c point-of-care (POC) analyzer in the Middle East and Africa. The quo-test analyzer is fully automated and quantifies HbA1c from a 4μL sample taken from a finger prick or venous whole blood.
However, studies have shown that the presence of genetic variants of hemoglobin can affect the accuracy of HbA1c measurements. Iron deficiency anemia and vitamin B12 deficiency can lead to falsely elevated HbA1c results. Such factors are challenging the adoption of the global HbA1c testing market.
Regionally, Asia-Pacific is anticipated to grow at a higher CAGR during the forecast period. Major factors contributing to the growth of the HbA1c testing market in this region include the rising geriatric population coupled with the rising incidence of diabetes. Moreover, growing government initiatives and rising awareness regarding diabetes management are also expected to drive the growth of the HbA1c market in the region. Whereas, North America held the largest share of the global HbA1c testing market. The growth of the market is mainly attributed to the growing need for continuous glucose level monitoring among diabetes patients, presence of a large number of laboratories providing HbA1c testing services, favorable reimbursement policies and the prominent players focused on launching new products
Some of the prominent players operating in the global HbA1c testing market include Abbott Laboratories Inc., Siemens Healthcare Private Limited, Arkray, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., PTS Diagnostics, Transasia Bio-Medicals Ltd., Danaher Corporation, Trinity Biotech plc, and Tosoh Corporation, among others.